CHRONIC KIDNEY DISEASE RAAS blockade and diastolic heart failure in chronic kidney disease

被引：6
|
作者：
Franssen, Casper F. M. [1 ]
Navis, Gerjan [1 ]
机构：
[1] Univ Med Ctr Groningen, Dept Nephrol, NL-9700 RB Groningen, Netherlands
来源：
NATURE REVIEWS NEPHROLOGY | 2013年 / 9卷 / 04期
关键词：
RENIN-ANGIOTENSIN INHIBITION;
D O I：
10.1038/nrneph.2013.39
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
New data from Ahmed et al. show that discharge prescriptions for renin-angiotensin-aldosterone inhibitor therapy are associated with a significant reduction in all-cause mortality in elderly patients with diastolic heart failure and chronic kidney disease (CKD). These observational data support the case for prospective studies of RAAS blockade in patients with CKD and diastolic heart failure. Franssen, C. F. M. & Navis, G. Nat. Rev. Nephrol. 9, 190-192 (2013); published online 12 March 2013; doi:10.1038/nrneph.2013.39
引用
收藏
页码：190 / 192
页数：4
相关论文
共 50 条
  • [41] Prevention of Heart Failure in Patients with Chronic Kidney Disease
    Raghban A.
    Kirsop J.
    Tang W.H.W.
    Current Cardiovascular Risk Reports, 2015, 9 (1) : 1 - 11
  • [42] Diabetes mellitus has the prognostic impact in chronic heart failure patients with chronic kidney disease but not without chronic kidney disease
    Fukunami, MMasatake
    Yamada, T.
    Morita, T.
    Furukawa, Y.
    Tamaki, S.
    Iwasaki, Y.
    Kawasaki, M.
    Kikuchi, A.
    Kondoh, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 322 - 322
  • [43] OPTIMAL MANAGEMENT OF CHRONIC HEART FAILURE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Zachariah, Donah
    Kaira, Philip A.
    Kaira, Paul R.
    JOURNAL OF RENAL CARE, 2009, 35 (01) : 2 - 10
  • [44] CHRONIC KIDNEY DISEASE IN THE EVALUATION OF COMORBIDITY IN PATIENTS WITH CHRONIC HEART FAILURE
    Efremova, E.
    Shutov, A.
    ATHEROSCLEROSIS, 2020, 315 : E263 - E264
  • [45] Xanthine metabolism in chronic heart failure patients with chronic kidney disease
    Smolianyk, K. Kateryna
    Bilchenko, A.
    Kolomiiets, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 138 - 138
  • [46] Inflammation-based scores predict chronic kidney disease progression in patients with chronic kidney disease and chronic heart failure
    Cai, Lu
    Su, Licong
    Hu, Ying
    Cai, Endi
    Xu, Hong
    Liu, Bicheng
    Weng, Jianping
    Chen, Chunbo
    Liu, Huafeng
    Yang, Qiongqiong
    Li, Hua
    Kong, Yaozhong
    Li, Guisen
    Wan, Qijun
    Zha, Yan
    Xu, Gang
    Shi, Yongjun
    Zhou, Yilun
    Su, Guobin
    Tang, Ying
    Gong, Mengchun
    RENAL FAILURE, 2024, 46 (02)
  • [47] Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
    Mari Katsumata
    Nobuhito Hirawa
    Koichiro Sumida
    Minako Kagimoto
    Yosuke Ehara
    Yuki Okuyama
    Megumi Fujita
    Akira Fujiwara
    Mayumi Kobayashi
    Yusuke Kobayashi
    Yuichiro Yamamoto
    Sanae Saka
    Keisuke Yatsu
    Tetsuya Fujikawa
    Yoshiyuki Toya
    Gen Yasuda
    Kouichi Tamura
    Satoshi Umemura
    Clinical and Experimental Nephrology, 2017, 21 : 858 - 865
  • [48] CLINICAL UTILITY OF BIOMARKERS IN CHRONIC KIDNEY DISEASE AND CHRONIC HEART FAILURE
    Zachariah, Donah
    Olechowski, Bartosz
    Kalra, Paul R.
    JOURNAL OF RENAL CARE, 2013, 39 (03) : 128 - 139
  • [49] Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
    Katsumata, Mari
    Hirawa, Nobuhito
    Sumida, Koichiro
    Kagimoto, Minako
    Ehara, Yosuke
    Okuyama, Yuki
    Fujita, Megumi
    Fujiwara, Akira
    Kobayashi, Mayumi
    Kobayashi, Yusuke
    Yamamoto, Yuichiro
    Saka, Sanae
    Yatsu, Keisuke
    Fujikawa, Tetsuya
    Toya, Yoshiyuki
    Yasuda, Gen
    Tamura, Kouichi
    Umemura, Satoshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (05) : 858 - 865
  • [50] Reversibility of chronic heart failure symptoms in chronic kidney disease patients
    Belov, V. V.
    Ilyicheva, O. E.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (01): : 68 - 72
12345